Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoximone plus Metoprolol in Advanced CHF
NCT00077948Phase 3Terminated
- Sponsor
- Gilead Sciences
- Start
- Jul 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enoximone in congestive heart failure (CHF), sponsored by Gilead Sciences. Started Jul 2003; status: terminated.
02
Drugs
enoximone
03
Conditions
congestive heart failure (CHF)
Beyond the preview
Go deeper on NCT00077948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077948.